0      0

AONN+ Annual 2020


SAT14 - Product Theater 9 | Considerations When Counseling Your Patients About DARZALEX FASPRO™ (non-CE) Presentation by Janssen


Nov 7, 2020 3:15pm ‐ Nov 7, 2020 4:15pm

Description

Learning Objectives:

  • Describe the mechanism of action (MOA) of DARZALEX FASPRO™ to patients
  • Review efficacy data for DARZALEX FASPRO™ and DARZALEX®
  • Explain the administration of DARZALEX FASPRO™ to patients and what to expect before, during, and after treatment
  • Discuss side effects of DARZALEX FASPRO
  • Review DARZALEX FASPRO™ Important Safety Information 
  • Review DARZALEX Important Safety Information

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content